Influence of methylprednisolone sodium succinate on bile-acid-induced acute gastric mucosal damage.
D000208:Acute Disease; D000287:Administration, Topical; D000632:Aminopyrine / Q000378:metabolism; D000818:Animals; D001647:Bile Acids and Salts / Q000008:administration & dosage / Q000502:physiology; D004285:Dogs; D005753:Gastric Mucosa / Q000098:blood supply / Q000187:drug effects*; D006859:Hydrogen / Q000378:metabolism; D007511:Ischemia; D008775:Methylprednisolone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012964:Sodium / Q000378:metabolism; D013276:Stomach Ulcer / Q000139:chemically induced / Q000517:prevention & control*; D014667:Vasopressins / Q000494:pharmacology
D001647:Bile Acids and Salts; D000632:Aminopyrine; D014667:Vasopressins; D006859:Hydrogen; D012964:Sodium; D008775:Methylprednisolone